Filament’s mission is to get safe, natural psychedelics into the hands of everyone who needs them, as soon as possible, by doing the hard extraction and drug discovery science to unlock their healing potential.
With a deep natural psychedelics IP portfolio that is rooted in novel extraction and purification methods, an accomplished botanical extraction management team, a Health Canada psilocybin Dealer’s License, and in-house GMP manufacturing capabilities, the company has built the foundation to support a rapidly growing drug discovery pipeline.
Perfected by nature over millions of years, natural psychedelics can be expertly extracted, puriﬁed, and made immediately available as powerful medicines, without harmful synthetic chemicals or residues.
Natural drug development allows Filament to discover possibly thousands of compounds within plants that could have psychedelic properties. It also offers the exciting potential to prove the “entourage effect” by identifying other compounds within plants that combine with psychedelic compounds to provide benefit.
Filament believes extractions from naturally occurring psychedelic plants are the path to reaching the most people in need. Filament’s work will include protecting and increasing the global reserves of psychedelic plants by growing them in controlled environments and producing them regeneratively where they occur in nature.